| Dr David Ryan Stone, DO | |
|
411 West Tipton Street, Seymour, IN 47274 | |
| (812) 523-4818 | |
| (812) 522-0579 |
| Full Name | Dr David Ryan Stone |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 411 West Tipton Street, Seymour, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750670733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 02004634A (Indiana) | Primary |
| 208000000X | Pediatrics | 02004634A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Schneck Medical Center | Seymour, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson County Schneck Memorial Hospital | 8224004585 | 108 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
Most research on child sexual-abuse survivors focuses on negative consequences such as depression and suicide. A new study instead examines factors associated with resilience and flourishing among adult survivors.
People of color are incarcerated at disproportionately higher rates than White people, and men of all races have higher rates of recidivism.
HemaQuest Pharmaceuticals presented data from new preclinical studies and early results from clinical trials of its lead drug candidate, HQK-1001, in sickle cell disease and beta thalassemia at the annual meeting of the American Society of Hematology in New Orleans.
› Verified 3 days ago
| Entity Name | Jackson County Schneck Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629143037 PECOS PAC ID: 8224004585 Enrollment ID: O20041029000584 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
Most research on child sexual-abuse survivors focuses on negative consequences such as depression and suicide. A new study instead examines factors associated with resilience and flourishing among adult survivors.
People of color are incarcerated at disproportionately higher rates than White people, and men of all races have higher rates of recidivism.
HemaQuest Pharmaceuticals presented data from new preclinical studies and early results from clinical trials of its lead drug candidate, HQK-1001, in sickle cell disease and beta thalassemia at the annual meeting of the American Society of Hematology in New Orleans.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Ryan Stone, DO 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 523-4818 | Dr David Ryan Stone, DO 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 523-4818 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
Most research on child sexual-abuse survivors focuses on negative consequences such as depression and suicide. A new study instead examines factors associated with resilience and flourishing among adult survivors.
People of color are incarcerated at disproportionately higher rates than White people, and men of all races have higher rates of recidivism.
HemaQuest Pharmaceuticals presented data from new preclinical studies and early results from clinical trials of its lead drug candidate, HQK-1001, in sickle cell disease and beta thalassemia at the annual meeting of the American Society of Hematology in New Orleans.
› Verified 3 days ago
Dr. Micah A Fischer, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 225 S Pine St, Jmb, 2nd Floor, Seymour, IN 47274 Phone: 812-524-4265 Fax: 812-524-4269 | |
Dr. David Edwin Dollens, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 209 S Walnut St, Seymour, IN 47274 Phone: 812-522-2700 Fax: 812-522-1057 | |
Dr. Christopher P Bunce, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 S Pine St Fl 2, Seymour, IN 47274 Phone: 812-523-4750 Fax: 812-523-4751 | |
Dr. Narinder S Dabhia, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-522-2349 Fax: 812-523-7838 | |
Dr. Swapna R Parikh, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 S Pine St, Suite 311, Seymour, IN 47274 Phone: 812-523-4750 | |
Dr. Jordan C. Maryfield, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-522-0480 Fax: 812-522-0195 | |
Douglas A Towriss, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Saint Louis Ave, Seymour, IN 47274 Phone: 812-522-4084 Fax: 812-523-2013 |